RhD血型不匹配异基因造血干细胞移植输血RhD血型选择

doi:10.3969/j.issn.1671-2587.2023.02.006

临床输血与检验 ›› 2023, Vol. 25 ›› Issue (2): 189-192.DOI: 10.3969/j.issn.1671-2587.2023.02.006

RhD血型不匹配异基因造血干细胞移植输血RhD血型选择

樊凤艳, 马越云

100142 北京,空军特色医学中心临床检验科

收稿日期:2023-01-19 发布日期:2023-04-25
通讯作者: 马越云,教授,主任医师,主要从事感染免疫方面的研究,（E-mail）mayueyun2020@163.com。
作者简介:樊凤艳,副主任医师,主要从事临床输血与检验研究,（E-mail）ffy042@163.com。

The Selection of RhD Blood Type in Blood Transfusion of RhD Mismatched Allogeneic Hematopoietic Stem Cell Transplantation

FAN Feng-yan, MA Yue-yun

Department of Clinical Laboratory, Air Force Medical Center, Beijing 100142

Received:2023-01-19 Published:2023-04-25

摘要/Abstract

摘要： RhD血型不匹配异基因造血干细胞移植在我国发生率很低,同时匮乏的RhD阴性血液资源难以满足这一类患者的输血需求。作者梳理了RhD血型不匹配的造血干细胞移植时RhD血型输血选择、临床预后及预防同种抗体产生方法的文献,以期为这类患者输血尤其是应急情况下输血时RhD血型选择提供依据。

关键词: RhD血型, 造血干细胞移植, 输血, 同种抗体

Abstract: The incidence of RhD mismatched allogeneic hematopoietic stem cell transplantation in China is very low. At the same time, the scarcity of RhD-negative blood resources makes it difficult to meet the transfusion needs of this group of patients. In order to provide basis for RhD blood group selection in blood transfusion, especially in emergency,this paper reviews the literature on RhD blood group selection, clinical outcomes and methods to prevention of alloantibody production in RhD mismatched hematopoietic stem cell transplantation.

Key words: RhD blood group, Hematopoietic stem cell transplantation, Blood transfusion, Alloantibodies

中图分类号:

R457.1

樊凤艳, 马越云. RhD血型不匹配异基因造血干细胞移植输血RhD血型选择[J]. 临床输血与检验, 2023, 25(2): 189-192.

FAN Feng-yan, MA Yue-yun. The Selection of RhD Blood Type in Blood Transfusion of RhD Mismatched Allogeneic Hematopoietic Stem Cell Transplantation[J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2023, 25(2): 189-192.

参考文献

[1] 李晨越,陈思恬,何芮,等.RhD主动免疫安全性研究[J].中国输血杂志,2021,34(5):489-493.
[2] 赵震,张冬霞,王晓宁,等.9684例输血患者Rh血型系统抗原频率及不规则抗体检测临床价值分析[J].中国实验诊断学,2020,24(1):139-141.
[3] AVENT N D,REID M E.The Rh blood group system:a review[J].Blood,2000,95(2):375-387.
[4] MIJOVIC A.Alloimmunization to RhD antigen in RhD-incompatible haemopoietic cell transplants with non-myeloablative conditioning[J].Vox Sang,2002,83(4):358-362.
[5] YAZER M,TRIULZI D.Detection of anti-D in D-recipients transfused with D+ red blood cells[J].Transfusion,2007,47(12):2197-2201.
[6] CID J,LOZANO M,KLEIN H G,et al.Matching for the D antigen in haematopoietic progenitor cell transplantation:definition and clinical outcomes[J].Blood Transfus,2014,12(3):301-306.
[7] LUO X D,KELLER M A,JAMES I,et al.Strategies to identify candidates for D variant genotyping[J].Blood Transfus,2018,16(3):293-301.
[8] BOGGIONE C T,LUJÁN BRAJOVICH M E,MATTALO NI S M,et al.Genotyping approach for non-invasive foetal RHD detection in an admixed population[J].Blood Transfus,2017,15(1):66-73.
[9] CARRERAS E,DUFOUR C,MOHTY M,et al.The EBMT Handbook:Hematopoietic Stem Cell Transplantation and Cellular Therapies[M].Cham:Springer International Publishing,2019.
[10] Stephen J.Forman等著.吴德沛,黄晓军主译.THOMAS造血干细胞移植[M].第5版.北京:中国科学技术出版社,2020:1169-1181.
[11] 雷红,董梅,李振才,等.Rh(D)血型不合的异基因外周血干细胞移植1例报告[J].北京医学,2008,30(2):122-123.
[12] WOREL N,BÖHM A,RABITSCH W,et al.Frequency and prognostic value of D alloantibodies after D-mismatched allogeneic hematopoietic stem cell transplantation after reduced-intensity conditioning[J].Transfusion,2012,52(6):1348-1353.
[13] TIWARI A K,ARORA D,AGGARWAL G,et al.Safety assessment of RhD-positive red cell transfusion in RhD-negative liver-transplant recipients:single-centre report from India[J].Indian J Med Res,2020,152(6):662-666.
[14] CASANUEVA M,VALDES M D,RIBERA M C.Lack of alloimmunization to D antigen in D-negative immunosuppressed liver transplant recipients[J].Transfusion,1994,34(7):570-572.
[15] CID J,LOZANO M,FERNÁNDEZ-AVILÉS F,et al.Anti-D alloimmunization after D-mismatched allogeneic hematopoietic stem cell transplantation in patients with hematologic diseases[J].Transfusion,2006,46(2):169-173.
[16] 国家质量监督检验检疫总局,中国国家标准化管理委员会.全血及成分血质量要求:GB 18469—2012[S].北京:中国标准出版社,2012.
[17] LOZANO M,CID J.The clinical implications of platelet transfusions associated with ABO or Rh(D) incompatibility[J].Transfus Med Rev,2003,17(1):57-68.
[18] WEINSTEIN R,SIMARD A,FERSCHKE J,et al.Prospective surveillance of D- recipients of D+ apheresis platelets:alloimmunization against D is not detected[J].Transfusion,2015,55(6):1327-1330.
[19] LIUMBRUNO G,BENNARDELLO F,LATTANZIO A,et al.Recommendations for the transfusion of plasma and platelets[J].Blood Transfus,2009,7(2):132-150.
[20] 罗观文,梁栋立,洪好武,等.Rh阴性抗-D人免疫球蛋白的研究进展[J].华西药学杂志,2019,34(2):179-182.
[21] QURESHI H,MASSEY E,KIRWAN D,et al.BCSH guideline for the use of anti-D immunoglobulin for the prevention of haemolytic disease of the fetus and newborn[J].Transfus Med,2014,24(1):8-20.
[22] DUNBAR N M.Does ABO and RhD matching matter for platelet transfusion?[J].Hematology Am Soc Hematol Educ Program,2020,2020(1):512-517.
[23] POSTON J N,SUGALSKI J,GERNSHEIMER T B,et al.Mitigation strategies for anti-D alloimmunization by platelet transfusion in haematopoietic stem cell transplant patients:a survey of NCCN® centres[J].Vox Sang,2020,115(4):334-338.

RhD血型不匹配异基因造血干细胞移植输血RhD血型选择

The Selection of RhD Blood Type in Blood Transfusion of RhD Mismatched Allogeneic Hematopoietic Stem Cell Transplantation

RichHTML

PDF

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

本文评价

关于本刊

作者中心

在线期刊

访问统计

联系我们

[1]	中国输血协会免疫血液学专业委员会. 输血依赖型地中海贫血（TDT）患者临床输血中国专家共识[J]. 临床输血与检验, 2023, 25(2): 163-169.
[2]	黄蓉, 张宁洁, 郝珂, 郭天虹, 黄雪原, 谷兰, 傅云峰, 黄远帅, 王勇军, 陈秉宇, 周岚, 桂嵘. 从《AABB技术手册》（18版-20版）看国际输血技术新走向^*[J]. 临床输血与检验, 2023, 25(2): 170-179.
[3]	邓桂花, 龙馨妍, 孙亚纯, 王雷萍, 张传国, 孟庆宝. 智慧型输血医学科的建设[J]. 临床输血与检验, 2023, 25(2): 185-189.
[4]	王瑞含, 彭娟, 刘浩, 刘久波. 回收式自体输血对高危剖宫产妇凝血功能及血液中胎儿成分的影响^*[J]. 临床输血与检验, 2023, 25(2): 215-219.
[5]	葛霜, 汪德清. 2021—2022年度输血医学研究进展^*[J]. 临床输血与检验, 2023, 25(2): 276-281.
[6]	谢东甫, 黄霞, 杨俊鸿, 孙洁, 张晰, 何涛. 国内外血液安全监测报告若干数据指标的比较与分析^*[J]. 临床输血与检验, 2023, 25(1): 16-20.
[7]	王胜蓝, 贵明飞, 华敏玉, 李鹏, 卓创近, 刘钟梅, 杨霞, 黄霞, 何涛. 急性输血不良反应发生时间调查及分析^*[J]. 临床输血与检验, 2023, 25(1): 33-37.
[8]	周姗姗, 荆亚楠, 侯晓燕, 薛亚飞, 张媛媛, 黄霞, 王敏. 某三甲医院2021~2022年276例输血不良反应回顾性分析^*[J]. 临床输血与检验, 2023, 25(1): 38-43.
[9]	程志祥, 任林, 曹红荣, 张玉, 王珊珊, 张国庆, 黄霞. 基于《血液安全监测指南》开展临床输血不良事件监测的探索^*[J]. 临床输血与检验, 2023, 25(1): 48-55.
[10]	刘志新, 吴晓双, 孟炜程, 王斐, 陈要臻, 尹文, 胡兴斌. 一种急性溶血性输血反应小鼠动物模型的建立^*[J]. 临床输血与检验, 2023, 25(1): 63-68.
[11]	温普生, 杨媛淇, 彭雪松, 何柏霖, 邓玉华. 140例儿童活体肝移植术中大量输血的高危因素分析^*[J]. 临床输血与检验, 2023, 25(1): 97-102.
[12]	黄华华, 何飞. 提高严重产后出血血液复苏工作效率的初步探讨^*[J]. 临床输血与检验, 2023, 25(1): 103-106.
[13]	冯志文, 杨健, 黄伟文, 覃美艳. 基于倾向性评分匹配法探讨血流动力学稳定的非静脉曲张性上消化道出血患者红细胞输注阈值^*[J]. 临床输血与检验, 2023, 25(1): 107-111.
[14]	陈蕊, 吕孟兴, 尹加忠, 沈经纬, 熊荣, 白云艳, 周文彪, 王旭, 杨琦, 屈柯暄. 云南省地中海贫血儿童输血安全策略的研究^*[J]. 临床输血与检验, 2022, 24(6): 710-715.
[15]	谢惠益, 周载鑫, 杨玥, 王星怡, 李津杞, 牟显尧, 顾海慧, 钱宝华. 抗-M抗体影响血型鉴定及对临床输血的影响^*[J]. 临床输血与检验, 2022, 24(6): 716-720.